Xilio Development Company Leadership
| XLO Stock | USD 0.70 0.01 0.71% |
About 67% of Xilio Development's corporate insiders are selling. The analysis of the overall insider sentiment regarding Xilio Development suggests that many insiders are alarmed. Xilio Development employs about 73 people. The company is managed by 12 executives with a total tenure of roughly 171 years, averaging almost 14.0 years of service per executive, having 6.08 employees per reported executive.
Xilio Development's Insider Buying Vs Selling
33
Selling | Buying |
Latest Trades
| 2025-01-02 | Kevin M Brennan | Disposed 1803 @ 0.98 | View | ||
| 2024-04-02 | Gilead Sciences, Inc. | Acquired 485250 @ 0.76 | View | ||
| 2024-02-08 | Venture Fund Xi L.P. Atlas | Disposed 733 @ 0.64 | View |
Monitoring Xilio Development's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Xilio |
Xilio Development Management Team Effectiveness
The company has Return on Asset of (0.5258) % which means that on every $100 spent on assets, it lost $0.5258. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.7096) %, meaning that it generated no profit with money invested by stockholders. Xilio Development's management efficiency ratios could be used to measure how well Xilio Development manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2025, Return On Tangible Assets is likely to drop to -1.51. In addition to that, Return On Capital Employed is likely to drop to -1.66. At this time, Xilio Development's Total Assets are very stable compared to the past year. As of the 1st of February 2025, Net Tangible Assets is likely to grow to about 127.6 M, while Non Currrent Assets Other are likely to drop about 937.9 K.As of the 1st of February 2025, Common Stock Shares Outstanding is likely to drop to about 21.9 M. In addition to that, Net Loss is likely to drop to about (83.4 M)
Xilio Development Workforce Comparison
Xilio Development is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,190. Xilio Development holds roughly 73.0 in number of employees claiming about 6% of equities under Health Care industry.
Xilio Development Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Xilio Development insiders, such as employees or executives, is commonly permitted as long as it does not rely on Xilio Development's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Xilio Development insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Xilio Development Notable Stakeholders
A Xilio Development stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Xilio Development often face trade-offs trying to please all of them. Xilio Development's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Xilio Development's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| PharmD BCPS | CEO President | Profile | |
| Kevin Brennan | Senior Accounting | Profile | |
| Martin MD | Pres RD | Profile | |
| Scott Coleman | Chief Officer | Profile | |
| Uli Bialucha | Chief Officer | Profile | |
| Bill Avery | VP Devel | Profile | |
| Caroline Hensley | Chief Officer | Profile | |
| BCPS PharmD | CEO Director | Profile | |
| Katarina MD | Chief Officer | Profile | |
| Julissa Viana | Vice Communications | Profile | |
| Stacey Davis | Chief Officer | Profile | |
| Christopher Frankenfield | Chief Officer | Profile |
About Xilio Development Management Performance
The success or failure of an entity such as Xilio Development often depends on how effective the management is. Xilio Development management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Xilio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Xilio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.44) | (1.51) | |
| Return On Capital Employed | (1.58) | (1.66) | |
| Return On Assets | (1.44) | (1.51) | |
| Return On Equity | (2.39) | (2.27) |
Xilio Development Workforce Analysis
Traditionally, organizations such as Xilio Development use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Xilio Development within its industry.Xilio Development Manpower Efficiency
Return on Xilio Development Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1M | |
| Net Loss Per Executive | 6.4M | |
| Working Capital Per Employee | 1.4M | |
| Working Capital Per Executive | 8.6M |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.